The data displays the prevalence of HIV among injection drug users in 2016, sorted by WHO world sub-regions. In that year, some 4% of users of injection drugs in North America were HIV-positive.
Southwest Asia | 28.8 |
Eastern and Southeastern Europe | 22.4 |
Africa | 11.2 |
Western and Central Europe | 10.6 |
South Asia | 10.3 |
East and Southeast Asia | 9.6 |
Central Asia and Transcaucasia | 7.5 |
Latin America and the Caribbean | 6.4 |
North America | 4 |
Oceania | 1.2 |
Near and Middle East | 0.4 |